| Literature DB >> 32183578 |
Jihane Aouni1,2, Jean Noel Bacro2, Gwladys Toulemonde2,3, Pierre Colin1, Loic Darchy1, Bernard Sebastien1.
Abstract
Dose selection is one of the most difficult and crucial decisions to make during drug development. As a consequence, the dose-finding trial is a major milestone in the drug development plan and should be properly designed. This article will review the most recent methodologies for optimizing the design of dose-finding studies: all of them are based on the modeling of the dose-response curve, which is now the gold standard approach for analyzing dose-finding studies instead of the traditional ANOVA/multiple testing approach. We will address the optimization of both fixed and adaptive designs and briefly outline new methodologies currently under investigation, based on utility functions.Keywords: Adaptive trials; design optimization; dose selection; patient allocation; utility functions
Mesh:
Year: 2020 PMID: 32183578 DOI: 10.1080/10543406.2020.1730874
Source DB: PubMed Journal: J Biopharm Stat ISSN: 1054-3406 Impact factor: 1.051